Vanderbilt

Nashville, Tennessee 37323

3 studies enrolling now · 43 studies all time

What they study most

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Advanced Solid Tumors, Alzheimer Disease, Aortic Valve Stenosis, Bladder Cancer, Breast, Breast Cancer, Breast Cancer Female, Breast Cancer, Early-Onset, Breast Disease

Studies at this site

• PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III — Recruiting now
• Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer — Recruiting now
• Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy — Recruiting now
• PROACTIVE-HF IDE Trial Heart Failure NYHA Class III — Running, not enrolling
• Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform — Completed
• Robotic vs. Open NSM for Early Stage Breast Cancer — Running, not enrolling
• Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma — Running, not enrolling
• Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study — Completed
• Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors — Completed
• Validation of a Multi-gene Test for Lung Cancer Risk — Running, not enrolling
• AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke — Stopped early
• Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients — Completed
• Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML — Completed
• Effect of Food on Blood Levels of ASTX727 — Completed
• A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer — Stopped early
• Adenosine Contrast CorrELations in Evaluating RevAscularizaTION — Completed
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial — Completed
• A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma — Stopped early
• A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors — Stopped early
• PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement — Completed
• Selinexor in Advanced Liposarcoma — Completed
• A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130) — Completed
• Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Clinical Setting (SC140121 Study 1 and 2) — Completed
• Pain Control Following Sinus Surgery — Completed
• Oral Antibiotics After 2-Stage Revision for Infected Total Hip Arthroplasty and Total Knee Arthroplasty — Completed
• Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma — Stopped early
• CleanUP IPF for the Pulmonary Trials Cooperative — Stopped early
• Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM — Completed
• Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors — Completed
• Insulin Resistance Intervention After Stroke Trial — Completed
• Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL) — Completed
• A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL]) — Completed
• A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
• Inflammation and the Heart — Completed
• A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors — Completed
• Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III — Completed
• Clinical Evaluation of Florbetapir F 18 (18F-AV-45) — Completed
• A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers — Completed
• Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib — Stopped early
• A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer — Stopped early
• Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer — Completed
• Addressing The Role of Nutrition Education & Health Literacy in Diabetes Care — Completed
• Pregabalin (Lyrica) for the Treatment of Essential Tremor — Completed